Cargando…

Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy

Non-small cell lung cancer (NSCLC) remains the most common cause of cancer-related mortality. The heterogeneous nature of this disease hinders its diagnosis and treatment, requiring continuous advances in research aiming to understand its intricate nature. Consequently, the retrospective analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Fernández, Coral, Fornaguera, Cristina, Borrós, Salvador
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352459/ https://www.ncbi.nlm.nih.gov/pubmed/32570729 http://dx.doi.org/10.3390/cancers12061609

Ejemplares similares

Engineering oncogene-targeted anisamide-functionalized pBAE nanoparticles as efficient lung cancer antisense therapies
por: Fornaguera, Cristina, et al.
Publicado: (2023)

Extracellular Vesicles and Their Current Role in Cancer Immunotherapy
por: Giacobino, Carla, et al.
Publicado: (2021)

Personalized Nanomedicine: A Revolution at the Nanoscale
por: Fornaguera, Cristina, et al.
Publicado: (2017)

Dual stimuli-responsive polyphosphazene-based molecular gates for controlled drug delivery in lung cancer cells
por: Salinas, Yolanda, et al.
Publicado: (2020)

Nanomedicine in Lung Cancer Immunotherapy
por: Doroudian, Mohammad, et al.
Publicado: (2023)

Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy
por: Arista-Romero, Maria, et al.
Publicado: (2021)

Methods for the In Vitro Characterization of Nanomedicines—Biological Component Interaction
por: Fornaguera, Cristina, et al.
Publicado: (2017)

Glycyrrhetinic Acid-Functionalized Mesoporous Silica Nanoparticles for the Co-Delivery of DOX/CPT-PEG for Targeting HepG2 Cells
por: Martínez-Edo, Gabriel, et al.
Publicado: (2020)

The emerging nanomedicine-based technology for non-small cell lung cancer immunotherapy: how far are we from an effective treatment
por: Peng, Lei, et al.
Publicado: (2023)

Nanomedicine and cancer immunotherapy
por: Yu, Hai-jun, et al.
Publicado: (2020)

Unravelling the role of individual components in pBAE/polynucleotide polyplexes in the synthesis of tailored carriers for specific applications: on the road to rational formulations
por: Navalón-López, María, et al.
Publicado: (2023)

Activation of cancer immunotherapy by nanomedicine
por: Wang, Lijuan, et al.
Publicado: (2022)

Complex pBAE Nanoparticle Cell Trafficking: Tracking Both Position and Composition Using Super Resolution Microscopy
por: Riera, Roger, et al.
Publicado: (2022)

Engineering Prodrug Nanomedicine for Cancer Immunotherapy
por: Yang, Bin, et al.
Publicado: (2020)

Nanomedicine for Combination Urologic Cancer Immunotherapy
por: Tian, Yun, et al.
Publicado: (2023)

Light-responsive nanomedicine for cancer immunotherapy
por: Kang, Weirong, et al.
Publicado: (2023)

Biomineralization in Three-Dimensional Scaffolds Based on Bacterial Nanocellulose for Bone Tissue Engineering: Feature Characterization and Stem Cell Differentiation
por: Cañas-Gutiérrez, Ana, et al.
Publicado: (2023)

Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers
por: Acebes-Fernández, Vanessa, et al.
Publicado: (2020)

Immunotherapy and the Treatment of Non–Small Cell Lung Cancer
por: Walker, Suzanne
Publicado: (2016)

Cancer nanomedicine meets immunotherapy: opportunities and challenges
por: Sun, Qingxue, et al.
Publicado: (2020)

Emerging nanomedicines for effective breast cancer immunotherapy
por: Bahreyni, Amirhossein, et al.
Publicado: (2020)

Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy
por: Dong, Xiao, et al.
Publicado: (2023)

Nanomedicine sheds new light on cancer immunotherapy
por: Yu, Yingying, et al.
Publicado: (2023)

Advances in Lung Cancer Treatment Using Nanomedicines
por: Sharma, Akshansh, et al.
Publicado: (2022)

Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review)
por: Volovat, Simona Ruxandra, et al.
Publicado: (2021)

Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy
por: Li, Wei, et al.
Publicado: (2020)

Polysaccharide-based nanomedicines for cancer immunotherapy: A review
por: Zeng, Yujun, et al.
Publicado: (2021)

Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
por: Peng, Shaojun, et al.
Publicado: (2021)

Emerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy
por: Yang, Yunrong, et al.
Publicado: (2022)

Engineering of Amphiphilic Erlotinib Analogue as Novel Nanomedicine for Non-Small Cell Lung Cancer Therapy
por: Cong, Mei, et al.
Publicado: (2023)

Application of an assay Cascade methodology for a deep preclinical characterization of polymeric nanoparticles as a treatment for gliomas
por: Fornaguera, Cristina, et al.
Publicado: (2018)

Cancer Nanomedicine Special Issue Review Anticancer Drug Delivery with Nanoparticles: Extracellular Vesicles or Synthetic Nanobeads as Therapeutic Tools for Conventional Treatment or Immunotherapy
por: Zocchi, Maria Raffaella, et al.
Publicado: (2020)

Immunotherapy for Non-Small Cell Lung Cancer
por: Yoon, Sung Ho
Publicado: (2014)

Nanomedicine and therapy of lung diseases
por: Garcia, Fabrício de Melo
Publicado: (2014)

Oligopeptide-modified poly(beta-amino ester)s-coated AdNuPARmE1A: Boosting the efficacy of intravenously administered therapeutic adenoviruses
por: Brugada-Vilà, Pau, et al.
Publicado: (2020)

Nanomedicine-based co-delivery of a calcium channel inhibitor and a small molecule targeting CD47 for lung cancer immunotherapy
por: Guo, Yuedong, et al.
Publicado: (2023)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
por: Brahmer, Julie R., et al.
Publicado: (2018)

Nanomedicines based on nanoscale metal-organic frameworks for cancer immunotherapy
por: Zhong, Xiao-fang, et al.
Publicado: (2020)

Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
por: Zhu, Yuefei, et al.
Publicado: (2020)

Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases
por: Carney, Christine P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ulo20qpjotpquhl26rso9p7vet